Column: 5C 18 -MS-II Column size: 4.6mmI.D.-150mm Mobile phase: Methanol/ H 2 = 60/40 Detection: UV254nm Sample: 1; Acetophenone (0.05μg) 2; Methyl Benzoate (0.5μg) 3; Benzene (2.0μg) 4; Toluene (2.0μg)
CSMSIL Application Data Column: Column size: 4.6mmI.D.-150mm Mobile phase: Methanol/ H 2 = 90/10 Detection: UV254nm Sample: Inj. Vol: 1; o-terphenyl (0.1mg/ml) 2; Triphenylene (0.01mg/ml) 1.0μl 5C 18 -AR-II α = 2.44 Column: Column size: 4.6mmI.D.-150mm Mobile phase: Methanol/ H 2 = 30/70 Detection: UV254nm Sample: o-; 2-Methoxyphenol [Guaiacol] (1.5mg/ml) m-; 3-Methoxyphenol (1.5mg/ml) p-; 4-Methoxyphenol [Hydroquinone Monomethyl Ether] (2.0mg/ml) Inj. Vol: 1.5μl 5C 18 -AR-II 5C 18 -MS-II α = 1.65 CH 3 5C 18 -MS-II o-terphenyl Triphenylene CH 3 CH 3 o- m- p- CSMSIL Application Data Column: 5C18-PAQ Column size: 4.6mmI.D.-150mm Mobile phase: 20mmol/l Phosphate(pH7) Detection: UV254nm, 0.16AUFS Sample: 1; Cytosine (0.1μg) 2; Uracil (0.1μg) 3; Guanine (0.1μg) 4; Thymine (0.1μg) 5; Adenine (0.1μg) H 2 H 1 Cytosine H H 2 Uracil H H H 2 3 Guanine H H 4 Thymine H 2 H 5 Adenine ACALAI TESQUE, IC CSMSIL Application Data CSMSIL Application Data Column: 3C 18 -EB Column size: 4.6mmI.D.-75mm Mobile phase: Methanol/ 20mmol/l Phosphate buffer(ph7.0) = 50/50 Temperature: 40 C Detection: UV254nm Sample: Inj.Vol.: Phenytoin [5,5-Diphenylhydantoin] (1.0mg/ml) 1.0μl Column: 3C 18 -EB Column size: 2.0mmI.D.-150mm Mobile phase: 0.1% Formic Acid-Acetonitrile/ H 2 = 15/85 Flow rate: 0.2 ml/min Temperature: 40 C Detection: ESI-MS, Positive, SIM Sample: 1; Ciprofloxacin (21mg/L) 2; Danofloxacin (25mg/L) 3; Enrofloxacin (25mg/L) 4; Sarafloxacin (25mg/L) Inj.Vol.: 1.0μl ACALAI TESQUE, IC ACALAI TESQUE, IC AP-1426
H3C H3C Si H3C CH3 CSMSIL Application Data Column: Column size: 4.6mmI.D.-150mm Mobile phase: A: Acetonitrile/ 20mmol/l Phosphate buffer(ph2.5) = 10/90 B: Acetonitrile/ 20mmol/l Phosphate buffer(ph2.5) = 30/70 B conc. 0 100% 20min Linear gradient Detection: UV280nm Sample: 1; Gallocatechin(GC) (0.80mg/ml) 2; Caffeine (0.08mg/ml) 3; Epigallocatechin(EGC) (0.80mg/ml) 4; Catechin (C) (0.40mg/ml) 5; Epicatechin(EC) (0.40mg/ml) 6; Epigallocatechin gallate(egcg) (0.20mg/ml) 7; Gallocatechin gallate(gcg) (0.40mg/ml) 8; Epicatechin gallate(ecg) (0.20mg/ml) 9; Catechin gallate(cg) (0.20mg/ml) Injection Vol. 1.0μl 5C 18 -MS-II Cholester ACALAI TESQUE, IC AP-1072 CSMSIL Application Data Column: Column size: 4.6mmI.D.-150mm Mobile phase: Methanol Detection: UV265nm Sample: 1; Vitamin D 2 [Calciferol] (0.3μg) 2; Vitamin D 3 (0.1μg) 5C 18 -MS-II Cholester ACALAI TESQUE, IC AP-1035
5C 18 -MS-II Cholester Column: Column size: 4.6mmI.D.-150mm Mobile phase: Methanol/ H 2 = 60/40 Detection: UV254nm Sample: 1; Toluene (3.3μg) 2; Chlorobenzene (3.3μg) 3; Bromobenzene (3.3μg) ACALAI TESQUE, IC AP-1046
CSMSIL Application Data Column: Column size: 4.6mmI.D.-150mm Mobile phase: A: 20mmol/l Phosphate buffer(ph2.5) B: Methanol B conc. 1050% 20min Linear gradient Detection: UV290nm Sample: 1; Chlorogenic Acid (0.1mg/ml) 2; Caffeine (0.1mg/ml) 3; Caffeic Acid [3,4-Dihydroxycinnamic Acid] (0.1mg/ml) Inj. Vol: 1.0μl H H H H H 1; Chlorogenic Acid 5C 18 -MS-II Cholester S PFP ACALAI TESQUE, IC AP-1266 5C 18 -AR-II Cholester Column: Column size: 4.6mmI.D.-150mm Mobile phase: Methanol Detection: UV254nm Sample: 1; Bibenzyl 2; Anthracene 10l Injection 40l Injection Bibenzyl Antharacene ACALAI TESQUE, IC
CSMCRE Application Data C S CSMCRE CSMCRE Column: Column size: 2.1mmI.D.-100mm Mobile phase: Methanol Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV280nm (Fully porous, 1.7μm, C 18 ) (Core-Shell, 2.6μm, C 18 ) 2.6C 18 2.6Cholester Sample: 1; Vitamin K 2 [Menatetrenone] (0.50mg/ml) 2; trans-vitamin K 1 (0.50mg/ml) Inj. Vol: 3; cis-vitamin K 1 0.5μl CH 3 CH 3 CH 3 H 3C ACALAI TESQUE, IC trans-vitamin K 1 CH 3 CH 3 AP-1407 CSMSIL Application Data C 1.7mC 18 CSMSIL 2.5Cholester Mobile phase: Acetonitrile/ 0.05%aH 2 P 4 aq. = 3/5 Flow rate: 0.7 ml/min Temperature: 50 C Detection: UV206nm Sample: 1; Saikosaponin c 2; Saikosaponin h 3; Saikosaponin a 4; Saikosaponin b 5; Saikosaponin b 2 1 6; Saikosaponin d Injection Vol. 1.0l 1 2 (2.1mmI.D.-50mm) 3,4 5 6 1 2 3 (2.0mmI.D.-50mm) 4 5 6 Data courtesy of a customer
Br Br Br Br Br H3C Si CH3 CSMSIL Application Data Column: HILIC Column size: 4.6mmI.D.-150mm Mobile phase: Acetonitrile/ H 2 = 90/10 Detection: UV260nm Undiluted sol. 1μl Injection 1/20 dilute sol. 20μl Injection Column: PBr Column size: 4.6mmI.D.- 150mm Mobile phase: H 2 Detection: UV260nm Undiluted sol. 1μl Injection 1/20 dilute sol. 20μl Injection Sample: 1; Uracil (0.1mg/ml) 2; Uridine (0.2mg/ml) Sam. Solution H 2 Sample: 1; Uracil (0.1mg/ml) 2; Uridine (0.2mg/ml) Sam. Solution H 2 H H H H H H H H 1; Uracil 2; Uridine ACALAI TESQUE, IC
5C 18 -PAQ PBr Column: Column size: 4.6mmI.D.-150mm Mobile phase: Methanol/ 20mmol/l Phosphate buffer(ph7.0) = 10/90 Detection: UV260nm Sample: 1; Adenosine 5 -triphosphate (0.5mg/ml) 2; Adenosine 5 -diphosphate (0.8mg/ml) 3; Adenosine 5 -monophosphate (0.8mg/ml) Inj.Vol.: 1.0μl H 2 H P P P Adenosine 5'-triphosphate ACALAI TESQUE, IC CSMCRE Application Data Column: CSMCRE 2.6PBr Column size: 2.1mmI.D.-150mm Mobile phase: A; 20mmol/l Phosphate buffer(ph2.5) B; Methanol/ 20mmol/l Phosphate buffer(ph2.5) = 60/40 B conc. 0% (0-1min), 0 80% (1 5min), 80 100% (5 9min) Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV220nm Sample: 1; Vitamin B 1 [Thiamine] (0.25mg/ml) 6; Vitamin B 5 [Pantothenic Acid] (2.0mg/ml) 2; Vitamin C [Ascorbic Acid] (1.0mg/ml) 7; Vitamin B 9 [Folic Acid] (0.2mg/ml) 3; Vitamin B 3 [icotinic Acid] (0.04mg/ml) 8; Vitamin B 7 [Biotin] (3.0mg/ml) 4; Vitamin B 3 [icotinamide] (0.06mg/ml) 9; Vitamin B 12 [Cyanocobalamin] (0.25mg/ml) 5; Vitamin B 6 [Pyridoxine] (0.25mg/ml) 10; Vitamin B 2 [Riboflavin] (0.2mg/ml) Inj. Vol: 1.25μl ACALAI TESQUE, IC
H3C Si CH3
CSMSIL Application Data 5C 18 -MS-II 5PE-MS AP Column: Column size: 4.6mmI.D.-150mm Mobile phase: Methanol/ 20mmol/l Phosphate buffer(ph2.5) 5C 18 -MS-II = 40/60 5PE-MS = 60/40 AP = 80/20 Detection: UV254nm Sample: 1; Palmatine (0.2g) 2; Berberine (0.2g) ACALAI TESQUE, IC AP-1024 CSMSIL Application Data Column: Column size: Mobile phase: C 18 ; Methanol/ H 2 = 40/60 π AP; Methanol/ H 2 = 55/45 Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV254nm C 1.7m, C 18 (2.1mmI.D.-50mm) S 2.6m, C 18 (Core-Shell) (2.1mmI.D.-50mm) CSMSIL 2.5C 18 -MS-II 2.5m, C 18 (2.0mmI.D.-50mm) CSMSIL 2.5AP 2.5m, (2.0mmI.D.-50mm) Sample: 1; Prednisone (0.375mg/ml) 2; Cortisone (0.375mg/ml) 3; Prednisolone (0.375mg/ml) 4; Hydrocortisone (0.375mg/ml) Inj. Vol: 0.5μl ACALAI TESQUE, IC
meso meso
CSMSIL Application Data Column: PBr Column size: 4.6mmI.D.-150mm Mobile phase: 20mmol/l Phosphate buffer(ph2.5) Detection: UV260nm Sample: 1; Uracil (0.1mg/ml) 2; 5-Aminouracil (0.1mg/ml) 3; 6-Azauracil (0.1mg/ml) Inj.Vol.: 1.0μl Column: HILIC Column size: 4.6mmI.D.-150mm Mobile phase: Acetonitrile/ 10mmol/l Ammonium Acetate = 90/10 Detection: UV260nm Sample: 1; Uracil (0.1mg/ml) 2; 5-Aminouracil (0.1mg/ml) 3; 6-Azauracil (0.1mg/ml) Inj.Vol.: 1.0μl ACALAI TESQUE, IC AP-1391 CSMSIL Application Data CSMSIL Application Data Column: 2.5HILIC Column size: 2.0mmI.D.-150mm Mobile phase: Acetonitrile/ 10mmol/l Phosphate buffer(ph7.0) = 50/50 Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV210nm Sample: 1; L-Glutamic Acid (2.5mg/ml) 2; Succinic Acid (4.0mg/ml) 3; Inosine-5'-monophosphate (0.25mg/ml) 4; Guanosine-5'-monophosphate (0.25mg/ml) Inj.Vol.: 1.0μl Column: 2.5HILIC Column size: 2.0mmI.D.-150mm Mobile phase: Acetonitrile/ 20mmol/l Phosphate buffer(ph7.0) = 70/30 Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV220nm Sample: 1; Angiotensin II(Human) (0.5mg/ml) 2; [Tyr(P 3 H 2 ) 4 ]-Angiotensin II(Human) (0.5mg/ml) Inj.Vol.: 2.0μl ACALAI TESQUE, IC AP-1276 ACALAI TESQUE, IC AP-1280
Column: Column size: 4.6mmI.D.-250mm Mobile phase: Acetonitrile / H 2 = 70/30 Detection: RI Sugar-D 5H 2 -MS Sample: 1; D-(-)-Arabinose 2; D-(+)-Galactose 3; Maltitol ACALAI TESQUE, IC
C C CH 2
trans cis trans cis
Column: Fully porous, 1.7μmCompetitor C, 1.7μm, C 18 Core-Shell, 2.6μmCSMCRE 2.6C 18 Column size: 2.1mmI.D.-100mm Mobile phase: Acetonitrile / Water = 60 / 40 Flow rate: Temperature: 40 C Detection: UV254nm Sample: 1; Benzene (2.0mg/ml) 2; Toluene (2.0mg/ml) 3; Ethylbenzene (2.0mg/ml) 4; Propylbenzene (2.0mg/ml) 5; Butylbenzene (2.0mg/ml) 6; Amylbenzene (2.0mg/ml) Inj.Vol.: 0.5μl C18, 1.7μm CC18 Pressure 39.3MPa (Peak 6) 18,000 C18, 2.6μm CSMCRE 2.6C18 Pressure 17.7MPa (Peak 6) 17,600 6.9 min C18, 2.6μm CSMCRE 2.6C18 Pressure 36.0MPa (Peak 6) 15,700 3.6 min
Column: CSMCRE 2.6C 18 Column size: 2.1mmI.D.-50mm Mobile phase: Acetonitrile / 20mmol/l Phosphate Buffer(pH7.0) = 60 / 40 Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV254nm Sample: 1; Amitriptyline (0.2mg/ml) 2; Amylbenzene (2.0mg/ml) Inj.Vol.: 0.5μl Column: CSMCRE 2.6C 18 Column size: 2.1mmI.D.-50mm Mobile phase: Acetonitrile / 20mmol/l Phosphoric Acid = 10 / 90 Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV254nm Sample: 1; xine-copper (0.003mg/ml) 2; Caffeine (0.3mg/ml) Inj.Vol.: 0.5μl CSMCRE Application Data C S CSMCRE CSMCRE Column: Column size: 2.1mmI.D.-100mm Mobile phase: Methanol Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV280nm (Fully porous, 1.7μm, C 18 ) (Core-Shell, 2.6μm, C 18 ) 2.6C 18 2.6Cholester Sample: 1; Vitamin K 2 [Menatetrenone] (0.50mg/ml) 2; trans-vitamin K 1 (0.50mg/ml) Inj. Vol: 3; cis-vitamin K 1 0.5μl CH 3 CH 3 CH 3 H 3C ACALAI TESQUE, IC trans-vitamin K 1 CH 3 CH 3 AP-1407 CSMCRE Application Data CSMCRE Application Data Column: CSMCRE 2.6PBr Column size: 2.1mmI.D.-150mm Mobile phase: 100mmol/l Phosphate buffer(ph2.5) Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV245nm Sample: 1; Thiamine Pyrophosphate (0.4mg/ml) 2; Thiamine (0.4mg/ml) Inj. Vol: 0.5μl Column: CSMCRE 2.6PBr Column size: 2.1mmI.D.-150mm Mobile phase: 100mmol/l Phosphate buffer(ph7.0) Flow rate: 0.4 ml/min Temperature: 40 C Detection: UV260nm Sample: 1; UDP (0.8mg/ml) 2; UDP-Galactose (0.8mg/ml) 3; UDP-Glucose (0.8mg/ml) Inj. Vol: 0.5μl H 2 H 2 + + S S H 3C H 3C H 3C H 3C H P P 1; Thiamine Pyrophosphate 2; Thiamine ACALAI TESQUE, IC H - P P - - H H P P - - H H P P - - 1; UDP 2; UDP-Galactose 3; UDP-Glucose ACALAI TESQUE, IC
H3C H3C H3C Si CH3 H3C Si CH3 H3C Si CH3 H